Release Simplifies the Participant Consent Process by Enabling Electronic Informed Consent (eConsent) within iMednet's eClinical Platform

通过在iMednet的eClinical平台内启用电子知情同意（已发送），版本简化了参与者的同意过程

MINNEAPOLIS, Oct. 4, 2023 /PRNewswire/ -- Today Mednet, a healthcare technology company, announced its latest software release featuring electronic consent capabilities (eConsent) within the iMednet eClinical platform. The new eConsent module was designed to provide a simple, cost-effective, and compliant method to collect and store participant consent - to accommodate the needs of hybrid, virtual and decentralized clinical trials, as well as to support the quest for greater participant diversity. .

明尼阿波利斯，2023年10月4日/PRNewswire/-今天，医疗保健技术公司Mednet宣布其最新软件版本，在iMednet eClinical平台内提供电子同意功能（eConsent）。新的eConsent模块旨在提供一种简单，具有成本效益和合规性的方法来收集和存储参与者同意-满足混合，虚拟和分散临床试验的需求，并支持寻求更大的参与者多样性。 .

Built as a native tool, iMednet eConsent, is highly configurable and fully integrated with the iMednet EDC-centric platform and other premium modules for a seamless user experience. Electronic consent provides an accessible, participant-centric process that saves time and breaks down geographical barriers, enabling researchers to connect with potential participants from around the world. In addition, features such as embedded media help to enhance participant comprehension of specific study protocol, potential risks and benefits, and the consent process..

作为本地工具iMednet eConsent构建，具有高度可配置性，并与iMednet EDC中心平台和其他高级模块完全集成，以实现无缝用户体验。电子同意提供了一个可访问的，以参与者为中心的过程，可以节省时间并打破地理障碍，使研究人员能够与来自世界各地的潜在参与者建立联系。此外，嵌入式媒体等功能有助于增强参与者对特定学习协议，潜在风险和收益以及同意过程的理解。。

'As the use of electronic consent in clinical trials becomes increasingly necessary across all study types – we are thrilled to add this to our comprehensive toolset,' said Rob Robertson, chief executive officer, Mednet. 'I am particularly proud of how our team diligently listened to our customers and translated their needs to deliver the optimal combination of functionality, flexibility, and affordability.'.

“随着所有研究类型在临床试验中使用电子同意变得越来越必要-我们很高兴将其添加到我们的综合工具集中，”Mednet首席执行官Rob Robertson说我特别自豪我们的团队如何努力倾听我们的客户，并翻译他们的需求，以提供功能，灵活性和可负担性的最佳组合。

With advances in medicine and technology changing the way clinical trials are designed and conducted, Mednet provides sponsors and CROs flexible, intuitive technologies to enable them to keep up with evolving industry requirements. The addition of eConsent significantly bolsters Mednet's ability to support studies ranging from small, early-stage studies to large, late-stage trials across all therapeutic areas..

随着医学和技术的进步改变了临床试验的设计和实施方式，Mednet为赞助商和CRO提供灵活，直观的技术，使他们能够跟上不断变化的行业需求。eConsent的加入显着增强了Mednet支持从小型早期研究到所有治疗领域的大型晚期试验的研究的能力。。

To learn more about the latest Mednet release and the iMednet platform, contact us.

要了解有关最新Mednet版本和iMednet平台的更多信息，请与我们联系。

About Mednet

关于Mednet

Mednet is a healthcare technology company specializing in eClinical solutions designed for the global life sciences community. Mednet's comprehensive, EDC-centric eClinical platform improves the efficiency of clinical studies of all types and sizes. Beyond electronic data capture (EDC), Mednet's solution set provides the tools required to build and manage all types of clinical research, while enabling organizations to adapt to evolving demands and requirements.

Mednet是一家医疗保健技术公司，专门为全球生命科学界设计临床解决方案。Mednet全面的，以EDC为中心的临床平台提高了所有类型和规模的临床研究效率。除了电子数据采集（EDC）之外，Mednet的解决方案集还提供了构建和管理所有类型临床研究所需的工具，同时使组织能够适应不断变化的需求和需求。

Pharmaceutical, medical device, biotechnology and Contract Research Organizations (CROs) around the world have trusted Mednet for over 22 years to deliver the technology innovation, experience and reliability they need for success. For more information, visit www.mednetsolutions.com..

世界各地的制药，医疗器械，生物技术和合同研究组织（CRO）已经信任Mednet超过22年，以提供他们成功所需的技术创新，经验和可靠性。欲了解更多信息，请访问www.mednetsolutions.com。。

Contact: Jenny Erasmus, [email protected]

联系方式：Jenny Erasmus，[电子邮件保护]

SOURCE Mednet

SOURCE Mednet